title: Public Relations: Ketchum brands new product with innovative PR strategy.
abstract: Novartis Pharmaceuticals tapped publis relations (PR) giant Ketchum earlier this year to spearhead a marketing campaign that would make its new U.S. Food and Drug Administration-approved prescription-based medication, Enablex, stand out among the crowd in over active bladder (OAB) treatment. OAB is a disorder that affects an estimated 33 million Americans making this treatment highly in demand with consumers and highly competitive with other pharmaceutical companies.
mesh_terms: D004345:Drug Industry; D006801:Humans; D040541:Marketing / Q000379:methods*; D009515:New Jersey; D019982:Organizational Case Studies; D004364:Pharmaceutical Preparations; D011641:Public Relations
chemical_list: D004364:Pharmaceutical Preparations